| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Mar 31, 2026 | Grant(A) | 17K | — | — | 17K |
| Mar 31, 2026 | Disposed to issuer(D) | 17K | — | — | 0 |
| Mar 31, 2026 | Grant(A) | 75K | — | — | 75K |
| Mar 31, 2026 | Disposed to issuer(D) | 75K | — | — | 0 |
| Mar 31, 2026 | Grant(A) | 7K | — | — | 7K |
| Mar 31, 2026 | Disposed to issuer(D) | 7K | — | — | 0 |
| Mar 31, 2026 | Grant(A) | 200K | — | — | 200K |
| Mar 31, 2026 | Disposed to issuer(D) | 200K | — | — | 0 |
| Mar 31, 2026 | Grant(A) | 150K | — | — | 150K |
| Mar 31, 2026 | Disposed to issuer(D) | 150K | — | — | 0 |
| Mar 31, 2026 | Grant(A) | 12K | — | — | 12K |
| Mar 31, 2026 | Disposed to issuer(D) | 12K | — | — | 0 |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-023356) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Skye Bioscience, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.